Patient, Oncologist, and Payer Preferences for Adjuvant Endocrine Therapy and CDK4/6 Inhibitor Regimens in Early-Stage Breast Cancer: A Discrete Choice Experiment

Overview of attention for article published in Patient preference and adherence, March 2021

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 7 Dimensions

Readers on

mendeley: 18 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 33,813 followers.

RT @PfizerOncMed: Understanding how therapy attributes impact treatment selection is important. See results from a web-based questionnaire…

24 Mar 2021

Reply Repost Favourite

Understanding how therapy attributes impact treatment selection is important. See results from a web-based questionnaire that describe patient, oncologist, and payer preferences that may guide early-stage #breastcancer treatment selection https://t.co/1IaT

23 Mar 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.